SADDLE RIVER, N.J., Nov. 6 /PRNewswire-FirstCall/ -- PDI, Inc. a contract sales and marketing services provider to the pharmaceutical industry, today announced the appointment of David N. Stievater to the newly created position of Senior Vice President, Emerging Pharma reporting directly to Mr. Michael Marquard, CEO. Mr. Stievater will join the company effective November 13, 2006 and will serve on the Executive Committee.
Mr. Stievater comes to PDI from ImpactRx, Inc., a provider of proprietary physician data for measuring pharmaceutical promotional effectiveness. At ImpactRx, Mr. Stievater served as V.P. Sales and V.P. Business Development and was a member of the executive team. He led the sales organization through a period of rapid expansion, more than doubling revenue and significantly expanding their customer base. Prior to ImpactRx, Mr. Stievater spent several years providing consulting services including marketing decision support to the biopharmaceutical industry, and concluded an eleven-year tenure with the Monitor Company Group, L.P. as Partner and Global Account Manager. He has advised pharmaceutical clients on such issues as sales force strategy and multi-channel physician marketing. Mr. Stievater began his career as a financial analyst at Merrill Lynch & Co. He earned his Masters in Business Administration from the University of Michigan and a Bachelor of Science degree from Georgetown University.
Mr. Michael Marquard, PDI’s CEO, stated, “We are delighted to have David join PDI as part of the management team. David is a highly credentialed executive who brings extensive business development expertise within the pharmaceutical industry, including emerging companies, which is an essential part of PDI’s growth strategy.”
Mr. Stievater stated, “This is a very exciting time to be joining PDI. As the pharmaceutical industry model continues to evolve, there is tremendous opportunity to better serve a wider range of companies with value added sales and marketing services. PDI’s expanded focus on earlier stage biotech and pharmaceutical clients establishes a broader base for solid growth. I look forward to having a significant impact on that effort.”
About PDI
PDI, Inc. is a contract sales and marketing services provider to the pharmaceutical industry offering a comprehensive set of outsourced solutions for established and emerging pharmaceutical companies. PDI is dedicated to maximizing the return on investment for its clients by providing strategic flexibility; sales, marketing, and commercialization expertise; and a philosophy of performance.
Headquartered in Saddle River, N.J., PDI operates in two segments, Sales Services and Marketing Services. Our sales services include our Performance Sales Teams(TM), which are dedicated teams for specific clients, and Select Access(TM), our targeted sales solution that leverages an existing infrastructure. Our marketing services include marketing research and consulting services through TVG in Dresher, PA, and medical communications services through Pharmakon in Schaumburg, IL. In addition, PDI is a high quality provider of ACCME-accredited continuing medical education through Vital Issues in Medicine (VIM (R)) in Dresher, PA. The company’s experience extends across multiple therapeutic categories and includes office and hospital-based initiatives.
PDI’s commitment is to deliver innovative solutions, unparalleled execution and superior results for its clients. Through strategic partnership and client-driven innovation, PDI maintains some of the longest standing sales and marketing relationships in the industry. Recognized as an industry pioneer, PDI remains committed to continuous innovation and to maintaining the industry’s highest quality employees.
For more information, visit the Company’s website at http://www.pdi-inc.com.
PDI, Inc.
CONTACT: Stephen P. Cotugno, Executive Vice President-CorporateDevelopment, of PDI, Inc., +1-201-574-8617
Web site: http://www.pdi-inc.com/
